APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antiretroviral Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antiretroviral Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025184 pages

Choose your research edition.

Industry ResearchAntiretroviral Drug Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiretroviral Drug Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Antiretroviral Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiretroviral Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiretroviral Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Antiretroviral Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Antiretroviral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antiretroviral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiretroviral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antiretroviral Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antiretroviral Drug include Boehringer-Ingelheim, Bristol-Myer Squibb, CIPLA, Gilead Sciences, ViiV Healthcare, AbbVie, Merck and Johnson and Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Antiretroviral Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antiretroviral Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antiretroviral Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Antiretroviral Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Antiretroviral Drug Segment by Company

Boehringer-Ingelheim

Bristol-Myer Squibb

CIPLA

Gilead Sciences

ViiV Healthcare

AbbVie

Merck

Johnson and Johnson

Antiretroviral Drug Segment by Type

Multi-Class Drugs Combination

Protease Inhibitors

NRTI

NNRTI

Other

Antiretroviral Drug Segment by Application

Hospital

Pharmaceutical Companies

Other

Antiretroviral Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiretroviral Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiretroviral Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiretroviral Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Antiretroviral Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antiretroviral Drug industry.

Chapter 3: Detailed analysis of Antiretroviral Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antiretroviral Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antiretroviral Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Multi-Class Drugs Combination Table 3. Key Players of Protease Inhibitors Table 4. Key Players of NRTI Table 3. Key Players of NNRTI Table 4. Key Players of Other Table 5. Global Antiretroviral Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospital Table 7. Key Players of Pharmaceutical Companies Table 8. Key Players of Other Table 9. Global Antiretroviral Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Antiretroviral Drug Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Antiretroviral Drug Market Share by Region (2021-2026) Table 12. Global Antiretroviral Drug Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Antiretroviral Drug Market Share by Region (2027-2032) Table 14. Antiretroviral Drug Industry Trends Table 15. Antiretroviral Drug Industry Drivers Table 16. Antiretroviral Drug Industry Opportunities and Challenges Table 17. Antiretroviral Drug Industry Restraints Table 18. Global Antiretroviral Drug Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Antiretroviral Drug Revenue Market Share by Company (2021-2026) Table 20. Global Antiretroviral Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Antiretroviral Drug Key Company Head Office and Area Served Table 22. Global Antiretroviral Drug Company, Product Type & Application Table 23. Global Antiretroviral Drug Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Antiretroviral Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Antiretroviral Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Antiretroviral Drug Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Antiretroviral Drug Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Antiretroviral Drug Revenue Market Share by Type (2021-2026) Table 30. Global Antiretroviral Drug Revenue Market Share by Type (2027-2032) Table 31. Global Antiretroviral Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Antiretroviral Drug Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Antiretroviral Drug Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Antiretroviral Drug Revenue Market Share by Application (2021-2026) Table 35. Global Antiretroviral Drug Revenue Market Share by Application (2027-2032) Table 36. Boehringer-Ingelheim Company Information Table 37. Boehringer-Ingelheim Business Overview Table 38. Boehringer-Ingelheim Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Boehringer-Ingelheim Antiretroviral Drug Product Portfolio Table 40. Boehringer-Ingelheim Recent Development Table 41. Bristol-Myer Squibb Company Information Table 42. Bristol-Myer Squibb Business Overview Table 43. Bristol-Myer Squibb Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Bristol-Myer Squibb Antiretroviral Drug Product Portfolio Table 45. Bristol-Myer Squibb Recent Development Table 46. CIPLA Company Information Table 47. CIPLA Business Overview Table 48. CIPLA Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. CIPLA Antiretroviral Drug Product Portfolio Table 50. CIPLA Recent Development Table 51. Gilead Sciences Company Information Table 52. Gilead Sciences Business Overview Table 53. Gilead Sciences Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Gilead Sciences Antiretroviral Drug Product Portfolio Table 55. Gilead Sciences Recent Development Table 56. ViiV Healthcare Company Information Table 57. ViiV Healthcare Business Overview Table 58. ViiV Healthcare Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. ViiV Healthcare Antiretroviral Drug Product Portfolio Table 60. ViiV Healthcare Recent Development Table 61. AbbVie Company Information Table 62. AbbVie Business Overview Table 63. AbbVie Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. AbbVie Antiretroviral Drug Product Portfolio Table 65. AbbVie Recent Development Table 66. Merck Company Information Table 67. Merck Business Overview Table 68. Merck Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Merck Antiretroviral Drug Product Portfolio Table 70. Merck Recent Development Table 71. Johnson and Johnson Company Information Table 72. Johnson and Johnson Business Overview Table 73. Johnson and Johnson Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Johnson and Johnson Antiretroviral Drug Product Portfolio Table 75. Johnson and Johnson Recent Development Table 76. North America Antiretroviral Drug Market Size by Type (2021-2026) & (US$ Million) Table 77. North America Antiretroviral Drug Market Size by Type (2027-2032) & (US$ Million) Table 78. North America Antiretroviral Drug Market Size by Application (2021-2026) & (US$ Million) Table 79. North America Antiretroviral Drug Market Size by Application (2027-2032) & (US$ Million) Table 80. North America Antiretroviral Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Antiretroviral Drug Market Size by Country (2021-2026) Table 82. North America Antiretroviral Drug Market Size by Country (2027-2032) Table 83. Europe Antiretroviral Drug Market Size by Type (2021-2026) & (US$ Million) Table 84. Europe Antiretroviral Drug Market Size by Type (2027-2032) & (US$ Million) Table 85. Europe Antiretroviral Drug Market Size by Application (2021-2026) & (US$ Million) Table 86. Europe Antiretroviral Drug Market Size by Application (2027-2032) & (US$ Million) Table 87. Europe Antiretroviral Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Europe Antiretroviral Drug Market Size by Country (2021-2026) Table 89. Europe Antiretroviral Drug Market Size by Country (2027-2032) Table 90. China Antiretroviral Drug Market Size by Type (2021-2026) & (US$ Million) Table 91. China Antiretroviral Drug Market Size by Type (2027-2032) & (US$ Million) Table 92. China Antiretroviral Drug Market Size by Application (2021-2026) & (US$ Million) Table 93. China Antiretroviral Drug Market Size by Application (2027-2032) & (US$ Million) Table 94. Asia Antiretroviral Drug Market Size by Type (2021-2026) & (US$ Million) Table 95. Asia Antiretroviral Drug Market Size by Type (2027-2032) & (US$ Million) Table 96. Asia Antiretroviral Drug Market Size by Application (2021-2026) & (US$ Million) Table 97. Asia Antiretroviral Drug Market Size by Application (2027-2032) & (US$ Million) Table 98. Asia Antiretroviral Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Asia Antiretroviral Drug Market Size by Country (2021-2026) Table 100. Asia Antiretroviral Drug Market Size by Country (2027-2032) Table 101. South America, Middle East & Africa Antiretroviral Drug Market Size by Type (2021-2026) & (US$ Million) Table 102. South America, Middle East & Africa Antiretroviral Drug Market Size by Type (2027-2032) & (US$ Million) Table 103. South America, Middle East & Africa Antiretroviral Drug Market Size by Application (2021-2026) & (US$ Million) Table 104. South America, Middle East & Africa Antiretroviral Drug Market Size by Application (2027-2032) & (US$ Million) Table 105. South America, Middle East & Africa Antiretroviral Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. South America, Middle East & Africa Antiretroviral Drug Market Size by Country (2021-2026) Table 107. South America, Middle East & Africa Antiretroviral Drug Market Size by Country (2027-2032) Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Antiretroviral Drug Product Image Figure 2. Global Antiretroviral Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Antiretroviral Drug Market Share by Type: 2025 VS 2032 Figure 4. Multi-Class Drugs Combination Image Figure 5. Protease Inhibitors Image Figure 6. NRTI Image Figure 7. NNRTI Image Figure 8. Other Image Figure 9. Global Antiretroviral Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Antiretroviral Drug Market Share by Application: 2025 VS 2032 Figure 11. Hospital Image Figure 12. Pharmaceutical Companies Image Figure 13. Other Image Figure 14. Global Antiretroviral Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 16. Global Antiretroviral Drug Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Antiretroviral Drug Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Antiretroviral Drug Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Antiretroviral Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Antiretroviral Drug Revenue Market Share by Type (2021-2032) Figure 23. Global Antiretroviral Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Antiretroviral Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 26. North America Antiretroviral Drug Market Share by Type (2021-2032) Figure 27. North America Antiretroviral Drug Market Share by Application (2021-2032) Figure 28. North America Antiretroviral Drug Market Share by Country (2021-2032) Figure 29. United States Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 30. Canada Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 32. Europe Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 33. Europe Antiretroviral Drug Market Share by Type (2021-2032) Figure 34. Europe Antiretroviral Drug Market Share by Application (2021-2032) Figure 35. Europe Antiretroviral Drug Market Share by Country (2021-2032) Figure 36. Germany Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 37. France Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 39. Italy Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 40. Russia Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 42. China Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 43. China Antiretroviral Drug Market Share by Type (2021-2032) Figure 44. China Antiretroviral Drug Market Share by Application (2021-2032) Figure 45. Asia Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 46. Asia Antiretroviral Drug Market Share by Type (2021-2032) Figure 47. Asia Antiretroviral Drug Market Share by Application (2021-2032) Figure 48. Asia Antiretroviral Drug Market Share by Country (2021-2032) Figure 49. Japan Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 53. India Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 54. Australia Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Antiretroviral Drug Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Antiretroviral Drug Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Antiretroviral Drug Market Share by Country (2021-2032) Figure 59. Brazil Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 64. UAE Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 66. Chile Antiretroviral Drug Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Multi-Class Drugs Combination
  • Protease Inhibitors
  • NRTI
  • NNRTI
  • Other
Applications
  • Hospital
  • Pharmaceutical Companies
  • Other
Companies covered
  • Boehringer-Ingelheim
  • Bristol-Myer Squibb
  • CIPLA
  • Gilead Sciences
  • ViiV Healthcare
  • AbbVie
  • Merck
  • Johnson and Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Antiretroviral Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Multi-Class Drugs Combination
  5. 1.2.3 Protease Inhibitors
  6. 1.2.4 NRTI
  7. 1.2.5 NNRTI
  8. 1.2.6 Other
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Antiretroviral Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Pharmaceutical Companies
  13. 1.3.4 Other
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Antiretroviral Drug Growth Trends by Region
  16. 1.5.1 Global Antiretroviral Drug Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Antiretroviral Drug Market Size by Region (2021-2026)
  18. 1.5.3 Antiretroviral Drug Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Antiretroviral Drug Market Dynamics
  1. 2.1 Antiretroviral Drug Industry Trends
  2. 2.2 Antiretroviral Drug Industry Drivers
  3. 2.3 Antiretroviral Drug Industry Opportunities and Challenges
  4. 2.4 Antiretroviral Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Antiretroviral Drug Revenue by Company (2021-2026)
  2. 3.2 Global Antiretroviral Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Antiretroviral Drug Key Company Head office and Area Served
  4. 3.4 Global Antiretroviral Drug Company, Product Type & Application
  5. 3.5 Global Antiretroviral Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Antiretroviral Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Antiretroviral Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Antiretroviral Drug Tier 1, Tier 2, and Tier 3
4 Antiretroviral Drug Market by Type
  1. 4.1 Global Antiretroviral Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Antiretroviral Drug Market Size by Type (2021-2032)
  3. 4.3 Global Antiretroviral Drug Market Size Share by Type (2021-2032)
5 Antiretroviral Drug Market by Application
  1. 5.1 Global Antiretroviral Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Antiretroviral Drug Market Size by Application (2021-2032)
  3. 5.3 Global Antiretroviral Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Boehringer-Ingelheim
  2. 6.1.1 Boehringer-Ingelheim Company Information
  3. 6.1.2 Boehringer-Ingelheim Business Overview
  4. 6.1.3 Boehringer-Ingelheim Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Boehringer-Ingelheim Antiretroviral Drug Product Portfolio
  6. 6.1.5 Boehringer-Ingelheim Recent Developments
  7. 6.2 Bristol-Myer Squibb
  8. 6.2.1 Bristol-Myer Squibb Company Information
  9. 6.2.2 Bristol-Myer Squibb Business Overview
  10. 6.2.3 Bristol-Myer Squibb Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Bristol-Myer Squibb Antiretroviral Drug Product Portfolio
  12. 6.2.5 Bristol-Myer Squibb Recent Developments
  13. 6.3 CIPLA
  14. 6.3.1 CIPLA Company Information
  15. 6.3.2 CIPLA Business Overview
  16. 6.3.3 CIPLA Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 CIPLA Antiretroviral Drug Product Portfolio
  18. 6.3.5 CIPLA Recent Developments
  19. 6.4 Gilead Sciences
  20. 6.4.1 Gilead Sciences Company Information
  21. 6.4.2 Gilead Sciences Business Overview
  22. 6.4.3 Gilead Sciences Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Gilead Sciences Antiretroviral Drug Product Portfolio
  24. 6.4.5 Gilead Sciences Recent Developments
  25. 6.5 ViiV Healthcare
  26. 6.5.1 ViiV Healthcare Company Information
  27. 6.5.2 ViiV Healthcare Business Overview
  28. 6.5.3 ViiV Healthcare Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 ViiV Healthcare Antiretroviral Drug Product Portfolio
  30. 6.5.5 ViiV Healthcare Recent Developments
  31. 6.6 AbbVie
  32. 6.6.1 AbbVie Company Information
  33. 6.6.2 AbbVie Business Overview
  34. 6.6.3 AbbVie Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 AbbVie Antiretroviral Drug Product Portfolio
  36. 6.6.5 AbbVie Recent Developments
  37. 6.7 Merck
  38. 6.7.1 Merck Company Information
  39. 6.7.2 Merck Business Overview
  40. 6.7.3 Merck Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Merck Antiretroviral Drug Product Portfolio
  42. 6.7.5 Merck Recent Developments
  43. 6.8 Johnson and Johnson
  44. 6.8.1 Johnson and Johnson Company Information
  45. 6.8.2 Johnson and Johnson Business Overview
  46. 6.8.3 Johnson and Johnson Antiretroviral Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Johnson and Johnson Antiretroviral Drug Product Portfolio
  48. 6.8.5 Johnson and Johnson Recent Developments
7 North America
  1. 7.1 North America Antiretroviral Drug Market Size (2021-2032)
  2. 7.2 North America Antiretroviral Drug Market Size by Type
  3. 7.2.1 North America Antiretroviral Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Antiretroviral Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Antiretroviral Drug Market Share by Type (2021-2032)
  6. 7.3 North America Antiretroviral Drug Market Size by Application
  7. 7.3.1 North America Antiretroviral Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Antiretroviral Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Antiretroviral Drug Market Share by Application (2021-2032)
  10. 7.4 North America Antiretroviral Drug Market Size by Country
  11. 7.4.1 North America Antiretroviral Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Antiretroviral Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Antiretroviral Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Antiretroviral Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Antiretroviral Drug Market Size (2021-2032)
  2. 8.2 Europe Antiretroviral Drug Market Size by Type
  3. 8.2.1 Europe Antiretroviral Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Antiretroviral Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Antiretroviral Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Antiretroviral Drug Market Size by Application
  7. 8.3.1 Europe Antiretroviral Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Antiretroviral Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Antiretroviral Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Antiretroviral Drug Market Size by Country
  11. 8.4.1 Europe Antiretroviral Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Antiretroviral Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Antiretroviral Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Antiretroviral Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Antiretroviral Drug Market Size (2021-2032)
  2. 9.2 China Antiretroviral Drug Market Size by Type
  3. 9.2.1 China Antiretroviral Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Antiretroviral Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Antiretroviral Drug Market Share by Type (2021-2032)
  6. 9.3 China Antiretroviral Drug Market Size by Application
  7. 9.3.1 China Antiretroviral Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Antiretroviral Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Antiretroviral Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Antiretroviral Drug Market Size (2021-2032)
  2. 10.2 Asia Antiretroviral Drug Market Size by Type
  3. 10.2.1 Asia Antiretroviral Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Antiretroviral Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Antiretroviral Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Antiretroviral Drug Market Size by Application
  7. 10.3.1 Asia Antiretroviral Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Antiretroviral Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Antiretroviral Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Antiretroviral Drug Market Size by Country
  11. 10.4.1 Asia Antiretroviral Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Antiretroviral Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Antiretroviral Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Antiretroviral Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Antiretroviral Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Antiretroviral Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Antiretroviral Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Antiretroviral Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Antiretroviral Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Antiretroviral Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Antiretroviral Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Antiretroviral Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Antiretroviral Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Antiretroviral Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Antiretroviral Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Antiretroviral Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Antiretroviral Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Antiretroviral Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst